Purpose

With this research we hope to begin to understand how rTMS can improve posttraumatic stress disorder (PTSD) symptoms. TMS improves PTSD through two interrelated mechanisms: change in brain limbic system function and change in systemic inflammatory activation. If you decide to join this study, you will receive ten rTMS treatments. All participants will undergo a 40-minute rTMS procedure with a member of the study team 10 times over 2-4 weeks. Participants will undergo fMRI scans of the head in order to help researchers better understand potential effects of rTMS on brain activity. In addition, you will be asked to give two breath and blood samples to look for general signs of inflammation.

Condition

Eligibility

Eligible Ages
Between 19 Years and 70 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 1. Age between 19 and 70 2. Moderate to severe PTSD as determined by a total score of at least 25 on the CAPS within 7 days of randomization. 3. Agree to have CAPS audio recorded. 4. Ability to obtain a Motor Threshold using the TMS device during screening. 5. Patient eligible for VA healthcare. 6. If female with childbearing potential, use of acceptable method of birth control (i.e., use of contraceptives, abstinence). 7. Able to read, understand, and sign the informed consent document.

Exclusion Criteria

  • 1. Pregnant or lactating woman. 2. Current use of clozapine (any dose) or bupropion (more than 300mg per day). 3. Cardiac pacemaker or implantable defibrillator. 4. Presence of any metal object in the head, including cochlear implants, but excluding dental work in the mouth. 5. Significant central nervous system disorder (stroke, brain mass, epilepsy). 6. Seizure in past one year. 7. Current psychosis or mania. 8. Significant suicidal ideation. 9. Unstable medical conditions. 10. Current alcohol or substance use disorder (except nicotine) that interferes with the patient's ability to participate. 11. CPT or PE for PTSD in the past 2 months. 12. Changes in Fluoxetine, Paroxetine, Sertraline, or Venlafaxine in the past 2 months. 13. MRI is contraindicated. 14. Currently participating in other research studies. 15. Aneurysm Clip 16. Ocular foreign body (e.g., metal shavings) 17. Any implanted device (pumps, infusion devices, etc.) 18. Shrapnel injuries or metal fragments

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Participants receiving open label trial of TMS
  • Device: Transcranial Magnetic Stimulation
    10 sessions of low frequency rTMS (1Hz) applied to the right dorsolateral prefrontal cortex.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
White River Junction Veterans Affairs Medical Center

Study Contact

Bradley V Watts, MD, MPH
802-295-9363
bradley.watts@va.gov

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.